Malcolm M. DeCamp Jr., MD Department of Surgery, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Written on May 8, 2023
I believe the AME Surgical Journal serves an unmet need in the world of surgical journals. I am honored to serve on the editorial board and to be a contributor!
Benjamin Wei, MD Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, AL, USA
Written on May 8, 2023
The journal focuses on thorough and high impact original research and coordinated, comprehensive review issues. These articles are supported by a highly qualified editorial board who maintain a high degree of scientific rigor in the article selection process.
Blayne Welk, MD, MSc, FRCSC Assistant Professor, Department of Surgery, Schulich School of Medicine and Dentistry, Western University, Ontario, Canada
The contributing authors to this journal are leaders in their respective field and the issues provide not only contemporary evidence based data and thoughtful commentary. I have personally used the TAU Urethral Stricture issue as a teaching tool for my residents.
John Stoffel, MD Service Chief Associate Chair of Ambulatory Urology Associate Director, Ambulatory Care UMHS
TAU distinguishes itself from other journals for its “Focused Issue” which collects the most updated researches, comprehensive reviews and commentaries on a specific disease or research area in each issue.
Xue-Song Li, MD, PhD Associate Professor, Department of Urology, Peking University First Hospital, Beijing, China
As Editor-in-Chief of ATM, I am proud to say that the journal is very unique in its incorporation of several different formats and reader participation. Each issue focuses on cutting edge topics in lung cancer and presents the information with the most up to date technological and multimedia advances. Due to its modern and innovative format, ATM is by far one of the most sought after journals by both physicians and researchers alike. ATM´s editorial team is very impressive, including a wide array of prestigious and internationally known investigators.
Rafael Rosell, MD Director, Cancer Biology and Precision Medicine Program, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Spain